Breast cellulitis following breast conservation therapy

A novel complication of medical progress

K. R. Mertz, L. M. Baddour, John Bell, J. L. Gwin

Research output: Contribution to journalComment/debate

35 Citations (Scopus)

Abstract

Breast cellulitis is a novel complication of the recently accepted practice of breast conservation therapy. This phenomenon represents an anatomic shift from ipsilateral upper extremity cellulitis seen in past years when mastectomy with axillary lymph node dissection was performed for treatment of limited disease due to breast cancer. Thirteen episodes of breast cellulitis in nine women who underwent breast conservation therapy for stage I or II breast cancer are presented. The mean duration from the end of radiotherapy to the initial episode of cellulitis was 4.9 months. Eighty- three percent of episodes occurred in patients who had radiologically demonstrated fluid collections at the surgical lumpectomy site prior to the onset of cellulitis. Eight (61.5%) of 13 episodes occurred within 3 months of a follow-up mammogram of the treated breast. Two patients developed recurrent cellulitis within a 6-month period. Breast cellulitis may be more commonly seen in clinical practice as an increasing number of patients undergo breast- sparing procedures for treatment of limited disease due to cancer.

Original languageEnglish (US)
Pages (from-to)481-486
Number of pages6
JournalClinical Infectious Diseases
Volume26
Issue number2
DOIs
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Cellulitis
Segmental Mastectomy
Breast
Breast Neoplasms
Mastectomy
Lymph Node Excision
Upper Extremity
Radiotherapy
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Breast cellulitis following breast conservation therapy : A novel complication of medical progress. / Mertz, K. R.; Baddour, L. M.; Bell, John; Gwin, J. L.

In: Clinical Infectious Diseases, Vol. 26, No. 2, 01.01.1998, p. 481-486.

Research output: Contribution to journalComment/debate

@article{7706cdd8fe0e49f6a622ec3e1c126912,
title = "Breast cellulitis following breast conservation therapy: A novel complication of medical progress",
abstract = "Breast cellulitis is a novel complication of the recently accepted practice of breast conservation therapy. This phenomenon represents an anatomic shift from ipsilateral upper extremity cellulitis seen in past years when mastectomy with axillary lymph node dissection was performed for treatment of limited disease due to breast cancer. Thirteen episodes of breast cellulitis in nine women who underwent breast conservation therapy for stage I or II breast cancer are presented. The mean duration from the end of radiotherapy to the initial episode of cellulitis was 4.9 months. Eighty- three percent of episodes occurred in patients who had radiologically demonstrated fluid collections at the surgical lumpectomy site prior to the onset of cellulitis. Eight (61.5{\%}) of 13 episodes occurred within 3 months of a follow-up mammogram of the treated breast. Two patients developed recurrent cellulitis within a 6-month period. Breast cellulitis may be more commonly seen in clinical practice as an increasing number of patients undergo breast- sparing procedures for treatment of limited disease due to cancer.",
author = "Mertz, {K. R.} and Baddour, {L. M.} and John Bell and Gwin, {J. L.}",
year = "1998",
month = "1",
day = "1",
doi = "10.1086/516322",
language = "English (US)",
volume = "26",
pages = "481--486",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Breast cellulitis following breast conservation therapy

T2 - A novel complication of medical progress

AU - Mertz, K. R.

AU - Baddour, L. M.

AU - Bell, John

AU - Gwin, J. L.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Breast cellulitis is a novel complication of the recently accepted practice of breast conservation therapy. This phenomenon represents an anatomic shift from ipsilateral upper extremity cellulitis seen in past years when mastectomy with axillary lymph node dissection was performed for treatment of limited disease due to breast cancer. Thirteen episodes of breast cellulitis in nine women who underwent breast conservation therapy for stage I or II breast cancer are presented. The mean duration from the end of radiotherapy to the initial episode of cellulitis was 4.9 months. Eighty- three percent of episodes occurred in patients who had radiologically demonstrated fluid collections at the surgical lumpectomy site prior to the onset of cellulitis. Eight (61.5%) of 13 episodes occurred within 3 months of a follow-up mammogram of the treated breast. Two patients developed recurrent cellulitis within a 6-month period. Breast cellulitis may be more commonly seen in clinical practice as an increasing number of patients undergo breast- sparing procedures for treatment of limited disease due to cancer.

AB - Breast cellulitis is a novel complication of the recently accepted practice of breast conservation therapy. This phenomenon represents an anatomic shift from ipsilateral upper extremity cellulitis seen in past years when mastectomy with axillary lymph node dissection was performed for treatment of limited disease due to breast cancer. Thirteen episodes of breast cellulitis in nine women who underwent breast conservation therapy for stage I or II breast cancer are presented. The mean duration from the end of radiotherapy to the initial episode of cellulitis was 4.9 months. Eighty- three percent of episodes occurred in patients who had radiologically demonstrated fluid collections at the surgical lumpectomy site prior to the onset of cellulitis. Eight (61.5%) of 13 episodes occurred within 3 months of a follow-up mammogram of the treated breast. Two patients developed recurrent cellulitis within a 6-month period. Breast cellulitis may be more commonly seen in clinical practice as an increasing number of patients undergo breast- sparing procedures for treatment of limited disease due to cancer.

UR - http://www.scopus.com/inward/record.url?scp=0031883065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031883065&partnerID=8YFLogxK

U2 - 10.1086/516322

DO - 10.1086/516322

M3 - Comment/debate

VL - 26

SP - 481

EP - 486

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 2

ER -